Melioidosis is potentially a life-threatening disease and is endemic in Northern Australia and Southeast Asia (5) . The etiological agent of melioidosis, Burkholderia pseudomallei, is a soil-and water-dwelling saprophyte capable of causing catastrophic systemic infections in humans and animals (7) . Melioidosis is now recognized as the most common cause of fatal community-acquired bacteremic pneumonia in two hyperendemic regions, northeastern Thailand and the Top End of the Northern Territory of Australia (5) .
An intriguing difference in melioidosis epidemiology in these two regions where melioidosis is hyperendemic is the lack of correlation between disease incidence and seropositivity in the respective populations. The average annual incidence of melioidosis in the Top End is 16.5 out of 100,000 (34.5 out of 100,000 in the heavy 1998 monsoonal season) with seropositivity ranging between 5 and 13% (5). In comparison, the annual incidence in Ubon Ratchathani in northeastern Thailand is 4.4 out of 100,000, where the majority of the rural population is seropositive (15) . Several explanations may account for these observations. In Thailand, underreporting of cases and protective immunity resulting from recurrent exposure may be factors, whereas in the Top End, a higher prevalence of risk factors for disease, such as diabetes and alcohol excess, and/or the presence of more virulent strains may be important (5) . Indeed, different isolates appear to have various levels of pathogenicity, as demonstrated in animal models and epidemiological studies. For example, the 50% lethal dose of 42 Australian and Papua New Guinean isolates ranged from 10 CFU to the least virulent of Ͼ10 6 CFU in B. pseudomalleisusceptible BALB/c mice (17) . Furthermore, our studies with isolates from a goat farm demonstrated that the predominant B. pseudomallei clone causing disease in the goats was underrepresented in the soil, while the common soil clones were rarely cultured from goats with melioidosis (unpublished data).
Many different approaches are presently under way to elucidate the mechanisms of B. pseudomallei pathogenesis, and several factors have been identified to date (10, 12, 18, 21) . Recently, the presence of type III secretion (TTS)-associated genes in B. pseudomallei was described (1, 19, 20) . A variety of gram-negative pathogens of animals and plants can use TTS systems to deliver virulence factors to host cells. The range of diseases caused by these pathogens in different hosts is reflected in the myriad of type III-secreted proteins (9). Winstanley et al. (19) identified a cluster of genes in B. pseudomallei with high similarity to genes of a horseradish peroxidase (hypersensitivity response and pathogenicity) locus in Ralstonia solanacearum and developed probes targeting a corresponding region in B. pseudomallei. Furthermore, mining of the B. pseudomallei genome has been used to identify a second related TTS gene cluster (11) and a region resembling the SPI-1 locus of Salmonella enterica serovar Typhimurium, including putative homologues of the effectors SipB and SopE which may be involved in apoptosis, cell fusion, and actinassociated membrane protrusion (1). PCR and genome sequence analyses indicate that, unlike the 50% lethal dose-like TTS cluster (TTS1), the other two TTS gene clusters are also present in Burkholderia thailandensis and Burkholderia mallei (11) . In this study, 116 clinical and environmental B. pseudomallei isolates collected in the Top End were screened for TTS1 genes. Some of these isolates exhibited relatively low virulence in mouse models and/or colonized patients without apparent disease. Environmental isolates were cultured from soil and water samples collected from various outback communities and rural and urban properties in the Top End by using Ashdown's medium (2) . Environmental B. pseudomallei organisms were identified by using an API 20E (bioMerieux, Marcy l'Etoile, France), polyclonal antibody-based latex agglutination, and diagnostic PCR (8) . Clinical isolates were identified by MicroScan Walkaway (Dade Diagnostics, Calif.), and veterinary isolates were identified by GN MicroPlate (Biolog, Calif.). Genomic DNA was extracted from Burkholderia strains (3), and TTS1 genes were amplified by using conditions previously described (20) . For the detection of TTS1 genes by Southern blotting and hybridization, samples of 1 g of genomic DNA cut with EcoRI were electrophoresed on a 0.8% agarose gel (13) . The probe was prepared by PCR amplification by using the primers described previously (20) and a cosmid clone containing the TTS1 genes as a template. The amplicon was labeled through five additional PCR cycles with [␣-32 P]dATP. All methods used were as described previously (13) . L-arabinose assimilation was determined by using GN MicroPlate, MicroScan Walkaway, or API 20E. Early isolates for which biochemical profiles were not available were tested on minimal agar medium supplemented with 0.2% (wt/vol) L-arabinose as described previously (16) .
None of the Top End human, veterinary, and environmental B. pseudomallei isolates in this study assimilated L-arabinose (Ara Ϫ ); in fact, no Ara ϩ strains (B. thailandensis) have been detected in Australia to date. PCR amplification of TTS1 genes was performed on 116 Top End B. pseudomallei isolates, 12 B. thailandensis isolates from Thailand, and a further 7 isolates of other Burkholderia species (Table 1 and Fig. 1 ). All human, environmental, and veterinary B. pseudomallei isolates from the Top End were positive for TTS1 genes by PCR. Other Burkholderia species (B. cepacia, B. spinosa, and B. vietnamiensis) commonly encountered by our laboratory in environmental specimens and the B. thailandensis isolates were negative by this test. These results were confirmed by Southern hybridization with the TTS1-specific probe (data not shown).
The ability of a strain of B. pseudomallei to cause clinical illness and the severity of the infection is undoubtedly related to host factors. In the Top End, 80% of melioidosis cases were identified as having one or more associated risk factors, including excessive alcohol consumption (39%), diabetes (37%), chronic lung disease (27%), chronic renal disease (10%), and other risk factors (20%) (4) . Furthermore, all but 1 of the 49 fatal cases had at least one identified risk factor (4) .
Nevertheless, results from several studies suggest that host factors are not alone in determining the onset and severity of melioidosis and that virulence levels vary between strains of B. pseudomallei. Further variables, including inoculating dose, time between infection and presentation, and the adequacy of treatment can influence clinical severity of melioidosis (17) . Our finding that all isolates contained TTS1 genes could not explain the reported variations in virulence among Top End isolates in BALB/c mice (17) .
An important marker of B. pseudomallei virulence is its inability to utilize L-arabinose as a sole energy source (Ara Ϫ ). In contrast, the antigenically cross-reacting Ara ϩ B. thailandensis strains rarely cause disease (6, 16) . Regional mapping of soils across Thailand demonstrated a correlation between the Ara Ϫ /Ara ϩ ratio in environmental isolates and incidence of melioidosis; a ratio of 1.7 in the northeastern hyperendemic region compared to 0.4 in central Thailand, where melioidosis cases are uncommon (16) . To date, all Top End environmental B. pseudomallei isolates have proven to be Ara Ϫ (5), which is consistent with the higher incidence of melioidosis in this region. Quantitative counts of environmental B. pseudomallei have also been correlated with disease incidence (14) and may play a role in this region.
In conclusion, TTS1 genes appear to be ubiquitous among Top End clinical and environmental strains of B. pseudomallei. This is consistent with its environmental existence and its relationship with plant hosts. The TTS1 amplicon was not present in other environmental Burkholderia species commonly encountered by our laboratory. Thus, PCR for TTS1 may prove highly useful for primary identification of B. pseudomallei in environmental samples. We are presently investigating its general applicability for diagnostic PCR. 
